Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma

NCT05075681 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Blood Stem Cell Transplantation

Interventions

DRUG: Modified By/Cy conditioning regimen intensified by Ruxolitinib and Chidamide

Sponsor

Chinese PLA General Hospital